PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma.
Clin Cancer Res
; 23(15): 4462-4472, 2017 Aug 01.
Article
in En
| MEDLINE
| ID: mdl-28270499
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Genes, MHC Class I
/
Proto-Oncogene Proteins c-myc
/
B7-H1 Antigen
/
N-Myc Proto-Oncogene Protein
/
Neuroblastoma
Type of study:
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
/
Middle aged
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2017
Document type:
Article
Affiliation country:
Italy
Country of publication:
United States